25C-NBF

25C-NBF (2C-C-NBF, NBF-2C-C) is a derivative of the phenethylamine hallucinogen 2C-C, which acts as a highly potent partial agonist for the human 5-HT_2A receptor.^[2][3][4] It produces psychoplastogenic and rapid antidepressant-like effects in preclinical research.^[4]

25C-NBF

Clinical data
Other names	2C-C-NBF; NBF-2C-C
ATC code	None
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics)[1] DE: NpSG (Industrial and scientific use only) UK: Class A
Identifiers
CAS Number	1539266-21-1 Y
PubChem CID	125181230
ChemSpider	32055558 Y
UNII	TF5JW72ANY

Society and culture

Legal status

Sweden

The Riksdag added 25C-NBF to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of January 26, 2016, published by Medical Products Agency (MPA) in regulation HSLF-FS 2015:35 listed as 25C-NBF, and 2-(4-kloro-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin.^[5]

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.^[6]

See also

• 25-NB (psychedelics)